Sign In
Buy BIIB
$207.94
+1.66 (+0.80%)
At Close: Aug 07, 2026
Will Biogen Inc. (BIIB) Beat Estimates Again in Its Next Earnings Report?
01:32pm, Wednesday, 11'th Oct 2023
Biogen Inc. (BIIB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Biogen Inc. (BIIB) Advances But Underperforms Market: Key Facts
07:32pm, Monday, 09'th Oct 2023
In the most recent trading session, Biogen Inc. (BIIB) closed at $264.21, indicating a +0.36% shift from the previous trading day.
Biogen gets FDA approval for biotech treatment similar to Roche's Actemra
04:25pm, Friday, 29'th Sep 2023
Biogen Inc. BIIB, -0.32% said late Friday the Food and Drug Administration approved its biosimilar version of Roche ROG, +0.30% ‘s arthritis treatment Actemra. Biogen said its treatment Tofidence, o
Is Biogen Stock a Buy Now?
10:07am, Thursday, 28'th Sep 2023
Biogen has faced a series of frustrations in its research efforts efforts in recent years. The biotech has improved its pipeline recently with new approvals and acquisitions.
Biogen Inc. (BIIB) Management presents at Decentralized Clinical Trials in Focus Conference (Transcript)
05:17pm, Tuesday, 26'th Sep 2023
Biogen Inc. (NASDAQ:BIIB ) Decentralized Clinical Trials in Focus Conference September 26, 2023 10:00 AM ET Company Participants Stephanie Manson Brown - Head of Clinical Development and Scientific In
Are Gene Therapy Stocks The Market's Next Big Winners?
08:06am, Monday, 25'th Sep 2023
It's not often that you see a company whose main product comes with a price tag of over $2 million, but that's the case with biotechs BioMarin Pharmaceutical NASDAQ: BMRN and Sarepta Therapeutics NASD
Japan approves Alzheimer treatment Leqembi by Eisai and Biogen
01:16am, Monday, 25'th Sep 2023
Japan's Eisai said on Monday the country's health ministry had approved its Alzheimer treatment Leqembi, co-developed with U.S.-based Biogen.
Biogen Inc. (BIIB) Morgan Stanley 21st Annual Global Healthcare Conference (Transcript)
02:47pm, Monday, 11'th Sep 2023
Biogen Inc. (NASDAQ:BIIB ) Morgan Stanley 21st Annual Global Healthcare Conference September 11, 2023 10:40 AM ET Company Participants Christopher Viehbacher - CEO Conference Call Participants Terence
Call of the day: The health care trade
01:30pm, Wednesday, 06'th Sep 2023
CNBC's Halftime traders Steve Weiss, Liz Young, Joe Terranova, and Brian Belski discuss the call of the day: health care.
Biogen names Dr. Jane Grogan head of research effective Oct. 2
07:40am, Wednesday, 06'th Sep 2023
Biogen Inc. BIIB said Wednesday it has appointed Dr. Jane Grogan as head of research, effective Oct. 2. Grogan was most recently chief scientific officer at Graphite Bio, a cell and gene editing compa
Biogen's (BIIB) Stock Outperforms Industry YTD: Here's Why
11:18am, Tuesday, 05'th Sep 2023
While most of Biogen's (BIIB) key drugs are facing declining sales, new products, like Leqembi in Alzheimer's disease, Qalsody in amyotrophic lateral sclerosis and zuranolone in depression, can help r
Better Buy: Biogen vs. Eli Lilly
10:07am, Tuesday, 29'th Aug 2023
Biogen is adding new products to its lineup to reverse its recent revenue decreases. Eli Lilly has a solid portfolio and strong pipeline, and pays a consistent dividend.
Biogen stock slips after FDA approves first biosimilar to Tysabri MS treatment
06:07pm, Thursday, 24'th Aug 2023
Biogen Inc. BIIB, -0.90% shares slipped in the extended session Thursday after the Food and Drug Administration granted a soon-to-be Novartis AG NVS, -1.94% spinoff approval for the first biosimilar t
With an Acquisition on the Way, Is Biogen Stock a Buy?
08:30am, Wednesday, 09'th Aug 2023
Biogen's planned acquisition will add an important product to its portfolio. The company's new Alzheimer's treatment should help it return to growth, too.
FDA approves first postpartum depression pill from Biogen, Sage
10:37am, Monday, 07'th Aug 2023
Yahoo Finance Health care reporter Anjalee Khemlani reports on the FDA approving Zurzuvae which is the first pill to treat postpartum depression.
